연구동향 분석

Paclitaxel-Coated Balloon Angioplasty for Early Restenosis of Central Veins in Hemodialysis Patients: A Single Center Initial Experience

Keerati Hongsakul Kittipitch Bannangkoon Sorracha Rookkapan Ussanee Boonsrirat Boonprasit Kritpracha 2018년

논문상세정보
인용/피인용

' Paclitaxel-Coated Balloon Angioplasty for Early Restenosis of Central Veins in Hemodialysis Patients: A Single Center Initial Experience' 의 참고문헌

  • Use of PTFE stent grafts for hemodialysis-related central venous occlusions: intermediate-term results
    Kundu S [2011]
  • Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
  • Treatment of hemodialysis-related central venous stenosis or occlusion: results of primary Wallstent placement and followup in 50 patients
    Haage P [1999]
  • The eternal tale of dialysis access vessels and restenosis: are drug-eluting balloons the solution?
  • The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study
  • Quality improvement guidelines for percutaneous management of the thrombosed or dysfunctional dialysis access
    Aruny JE [2003]
  • Pharmacomechanical thrombolysis versus surgical thrombectomy for the treatment of thrombosed haemodialysis grafts
    Hongsakul K [2015]
  • Pharmacomechanical thrombolysis for the treatment of thrombosed native arteriovenous fistula: a single-center experience
  • Percutaneous treatment of central venous stenosis in hemodialysis patients: long-term outcomes
    Kim YC [2009]
  • Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results
    Quinn SF [1995]
  • Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial
    Katsanos K [2012]
  • Paclitaxel-coated balloon angioplasty of venous stenoses in native dialysis fistulas: primary and secondary patencies at 6 and 12 months
    Verbeeck N [2016]
  • Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas
    Massmann A [2015]
  • Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery
    Axel DI [1997]
  • Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study
    Swinnen JJ [2015]
  • Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients
    Bakken AM [2007]
  • Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg
    Tepe G [2008]
  • Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial
    Werk M [2008]
  • Endovascular management of central venous stenoses in the hemodialysis patient: results of percutaneous therapy
    Surowiec SM [2004]
  • Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients
  • Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472)
    Kitrou PM [2015]
  • Drug-coated balloons to improve femoropopliteal artery patency: rationale and design of the LEVANT 2 trial
    Jaff MR [2015]
  • Clinical practice guidelines for vascular access
  • Central vein obstruction in hemodialysis patients: results of radiological and surgical intervention
    Dammers R [2003]